PDAC - Pancreatic Ductal Adenocarcinoma
Oncology
0
Pipeline Programs
1
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Verona PharmactDNA analysis
Verona PharmaRegister
Clinical Trials (2)
Total enrollment: 3,165 patients across 2 trials
Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability
Start: Dec 2022Est. completion: May 2026165 patients
N/ARecruiting
Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer
Start: Dec 2022Est. completion: Sep 20523,000 patients
N/ARecruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
5m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
5m ago
Office Administrator
SystImmune
6m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
16m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
20m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
20m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 3,165 patients
1 companies competing in this space